Ironwood Capital logo

Ironwood Capital

North America, Connecticut, United States, Avon

Description

Ironwood Capital is a Connecticut-based private equity firm providing non-control growth capital to middle market businesses.

Investor Profile

Ironwood Capital has made 34 investments, with 1 in the past 12 months and 21% as lead.

Stage Focus

  • Private Equity (38%)
  • Seed (15%)
  • Series Unknown (12%)
  • Series B (12%)
  • Series A (9%)
  • Series C (9%)
  • Series D (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Manufacturing
  • Software
  • Medical Device
  • Medical
  • Financial Services
  • Fintech
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ironwood Capital frequently co-invest with?

Elm Street Ventures
North America, Connecticut, United States, New Haven
Co-Investments: 2
LaunchCapital
North America, Connecticut, United States, New Haven
Co-Investments: 2
Spring Mountain Capital
North America, New York, United States, New York
Co-Investments: 3
HighCape Partners
North America, Maryland, United States, Baltimore
Co-Investments: 2
BASF Venture Capital
Europe, Rheinland-Pfalz, Germany, Ludwigshafen
Co-Investments: 2
NS
North America, Connecticut, United States, Greenwich
Co-Investments: 2
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 11
Advantage Capital
North America, Louisiana, United States, New Orleans
Co-Investments: 13
National Brain Tumor Society
North America, Massachusetts, United States, Newton
Co-Investments: 2
Xeraya Capital
Asia, Kuala Lumpur, Malaysia, Kuala Lumpur
Co-Investments: 2

What are some of recent deals done by Ironwood Capital?

H3 Manufacturing Group

Champaign, Illinois, United States

H3 Manufacturing Group manufactures CNC machining, sheet metal fabrication and provides welding, finishing, and assemblies for industries.

Manufacturing
Private EquityMar 7, 2025
Modifi Bio

New Haven, Connecticut, United States

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

BiotechnologyMedicalTherapeutics
SeedOct 16, 2023
Amount Raised: $4,300,000
Le Sueur Incorporated

Le Sueur, Minnesota, United States

Le Sueur offers sand casting, permanent mold, and die-casting services.

Mining
Private EquityJan 5, 2023
Torigen Pharmaceuticals

Farmington, Connecticut, United States

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

BiotechnologyHealth CareOncologyVeterinary
Series ANov 16, 2022
Amount Raised: $13,000,000
Modifi Bio

New Haven, Connecticut, United States

Modifi Biosciences is a leader in direct DNA modification and the development of novel cancer therapeutics.

BiotechnologyMedicalTherapeutics
SeedJul 28, 2022
Amount Raised: $6,400,000
Directional Services

Hope Mills, North Carolina, United States

Directional Services provides licensed electrical, utility contractor electrical, and solar construction services.

Service Industry
Private EquityJun 7, 2022
P2 Science

Woodbridge, Connecticut, United States

P2 Science develops a bio-refining process for the conversion of biomass such as vegetable oils into high-value specialty chemicals.

BiotechnologyChemicalRenewable Energy
Series CJan 29, 2020
Amount Raised: $12,000,000
IsoPlexis

Branford, Connecticut, United States

IsoPlexis is a life science technology company that develops a single-cell detection system identifying patient immune responses.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CJan 9, 2020
Amount Raised: $20,000,000
Payveris

Cromwell, Connecticut, United States

Payveris operates a cloud-based digital payment and money transfer platform.

Cloud ComputingFinanceFinancial ServicesFinTechInformation TechnologyPaymentsSoftware
Series DJun 13, 2019
Amount Raised: $7,000,000
IsoPlexis

Branford, Connecticut, United States

IsoPlexis is a life science technology company that develops a single-cell detection system identifying patient immune responses.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CMay 14, 2019
Amount Raised: $25,000,000